Terns Pharmaceuticals, Inc. (TERN): 25-NSE filed May 5, 2026

Form type
25-NSE
Filing date
May 5, 2026
Accession number
0001354457-26-000405
Filer
Terns Pharmaceuticals, Inc. (CIK 1831363)